Cite
Servant R, Garioni M, Vlajnic T, et al. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. J Pathol. 2021;254(5):543-555doi: 10.1002/path.5698.
Servant, R., Garioni, M., Vlajnic, T., Blind, M., Pueschel, H., Müller, D. C., Zellweger, T., Templeton, A. J., Garofoli, A., Maletti, S., Piscuoglio, S., Rubin, M. A., Seifert, H., Rentsch, C. A., Bubendorf, L., & Le Magnen, C. (2021). Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. The Journal of pathology, 254(5), 543-555. https://doi.org/10.1002/path.5698
Servant, Raphaëlle, et al. "Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens." The Journal of pathology vol. 254,5 (2021): 543-555. doi: https://doi.org/10.1002/path.5698
Servant R, Garioni M, Vlajnic T, Blind M, Pueschel H, Müller DC, Zellweger T, Templeton AJ, Garofoli A, Maletti S, Piscuoglio S, Rubin MA, Seifert H, Rentsch CA, Bubendorf L, Le Magnen C. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. J Pathol. 2021 Aug;254(5):543-555. doi: 10.1002/path.5698. Epub 2021 Jun 02. PMID: 33934365; PMCID: PMC8361965.
Copy
Download .nbib